HEADER HYDROLASE 06-MAR-08 3CH0 TITLE CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE TITLE 2 (YP_677622.1) FROM CYTOPHAGA HUTCHINSONII ATCC 33406 AT 1.50 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.1.4.46; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CYTOPHAGA HUTCHINSONII ATCC 33406; SOURCE 3 ORGANISM_TAXID: 269798; SOURCE 4 STRAIN: NCIMB 9469; SOURCE 5 GENE: YP_677622.1, UGPQ, CHU_1005; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_677622.1, GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3CH0 1 REMARK SEQADV REVDAT 5 24-JUL-19 3CH0 1 REMARK LINK REVDAT 4 25-OCT-17 3CH0 1 REMARK REVDAT 3 13-JUL-11 3CH0 1 VERSN REVDAT 2 24-FEB-09 3CH0 1 VERSN REVDAT 1 18-MAR-08 3CH0 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER JRNL TITL 2 PHOSPHODIESTERASE (YP_677622.1) FROM CYTOPHAGA HUTCHINSONII JRNL TITL 3 ATCC 33406 AT 1.50 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 56166 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2816 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3906 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 205 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2148 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.78 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.59000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : -0.68000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.062 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.066 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.045 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.184 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2395 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1658 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3222 ; 1.655 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4067 ; 0.974 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 297 ; 5.943 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 103 ;36.228 ;25.146 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 425 ;12.457 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;19.667 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 362 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2625 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 447 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 516 ; 0.211 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1884 ; 0.195 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1180 ; 0.177 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1191 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 305 ; 0.147 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.266 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 37 ; 0.226 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.136 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1556 ; 2.112 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 573 ; 0.521 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2362 ; 2.624 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1021 ; 4.227 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 860 ; 5.273 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 4. CITRATE (CIT) AND GLYCEROL (GOL) MOLECULES FROM REMARK 3 CRYSTALLIZATION AND ETHYLENE GLYCOL (EDO) FROM CRYO SOLUTION REMARK 3 WERE MODELED. REMARK 4 REMARK 4 3CH0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046765. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97910 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56237 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.553 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.70700 REMARK 200 R SYM FOR SHELL (I) : 0.70700 REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 14.0% PEG 4000, 24.227% 2 REMARK 280 -PROPANOL, 5.0% GLYCEROL, 0.1M CITRIC ACID PH 5.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.76600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.84950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.60550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.84950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.76600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.60550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE CRYSTAL PACKING ANALYSIS SUPPORTS REMARK 300 THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIZATION REMARK 300 STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 104 CE NZ REMARK 470 LYS A 125 CD CE NZ REMARK 470 LYS A 129 CD CE NZ REMARK 470 LYS A 203 NZ REMARK 470 LYS A 226 CD CE NZ REMARK 470 LYS A 271 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 16 66.88 -169.88 REMARK 500 ASN A 144 -7.99 73.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 272 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 273 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 274 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 277 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 278 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 279 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 280 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 281 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 282 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 283 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 284 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 285 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 286 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 287 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 289 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 367128 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3CH0 A 1 271 UNP Q11WD4 Q11WD4_CYTH3 1 271 SEQADV 3CH0 GLY A 0 UNP Q11WD4 EXPRESSION TAG SEQRES 1 A 272 GLY MSE ILE GLN VAL PRO ALA SER PHE ASP ILE GLN GLY SEQRES 2 A 272 HIS ARG GLY CYS ARG GLY LEU LEU PRO GLU ASN THR ILE SEQRES 3 A 272 ALA ALA PHE THR LYS ALA LEU LEU LEU GLY VAL THR THR SEQRES 4 A 272 LEU GLU PHE ASP LEU VAL ILE SER LYS ASP ASN ARG VAL SEQRES 5 A 272 VAL VAL SER HIS ASP THR PHE PHE HIS HIS GLU ILE THR SEQRES 6 A 272 MSE MSE VAL ASP GLY GLU ASP VAL THR GLU ALA ASN GLU SEQRES 7 A 272 LYS ASN PHE ASN LEU TYR ALA MSE ASN TYR ALA ASP ILE SEQRES 8 A 272 LYS GLU ILE ASP VAL GLY MSE LYS THR HIS PRO ARG PHE SEQRES 9 A 272 LYS SER GLN LYS LYS VAL PRO ALA VAL LYS PRO LEU PHE SEQRES 10 A 272 ARG GLU LEU ILE GLU THR ALA GLU LYS LEU SER ALA LYS SEQRES 11 A 272 ILE GLN TYR ASN GLY GLU ILE LYS SER THR VAL GLU GLY SEQRES 12 A 272 ASP ASN ILE ASP HIS PRO ASN ILE ALA LEU PHE CYS ASP SEQRES 13 A 272 LEU VAL VAL ALA GLU ILE LYS LYS ALA HIS ILE THR ASP SEQRES 14 A 272 ARG PHE THR LEU GLN SER PHE ASP VAL ARG ALA LEU GLU SEQRES 15 A 272 TYR MSE HIS SER GLN TYR PRO ASP ILE LYS LEU SER TYR SEQRES 16 A 272 LEU VAL GLU THR LYS GLY THR LEU LYS LYS GLN LEU GLU SEQRES 17 A 272 LYS LEU SER PHE THR PRO ALA VAL TYR SER PRO ASP VAL SEQRES 18 A 272 THR LEU VAL SER LYS LYS ASP ILE ASP ALA ALA HIS LYS SEQRES 19 A 272 LEU GLY MSE ARG VAL ILE PRO TRP THR VAL ASN THR LYS SEQRES 20 A 272 GLU GLU ILE GLU THR LEU ILE SER LEU GLY VAL ASP GLY SEQRES 21 A 272 ILE ILE THR ASP TYR PRO ASP LEU PHE PHE GLU LYS MODRES 3CH0 MSE A 1 MET SELENOMETHIONINE MODRES 3CH0 MSE A 65 MET SELENOMETHIONINE MODRES 3CH0 MSE A 66 MET SELENOMETHIONINE MODRES 3CH0 MSE A 85 MET SELENOMETHIONINE MODRES 3CH0 MSE A 97 MET SELENOMETHIONINE MODRES 3CH0 MSE A 183 MET SELENOMETHIONINE MODRES 3CH0 MSE A 236 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 65 8 HET MSE A 66 16 HET MSE A 85 8 HET MSE A 97 8 HET MSE A 183 8 HET MSE A 236 8 HET CIT A 272 13 HET EDO A 273 4 HET EDO A 274 4 HET EDO A 275 4 HET EDO A 276 4 HET EDO A 277 4 HET EDO A 278 4 HET EDO A 279 4 HET EDO A 280 4 HET EDO A 281 4 HET EDO A 282 8 HET EDO A 283 4 HET EDO A 284 4 HET EDO A 285 4 HET EDO A 286 4 HET EDO A 287 4 HET EDO A 288 4 HET GOL A 289 12 HETNAM MSE SELENOMETHIONINE HETNAM CIT CITRIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MSE 7(C5 H11 N O2 SE) FORMUL 2 CIT C6 H8 O7 FORMUL 3 EDO 16(C2 H6 O2) FORMUL 19 GOL C3 H8 O3 FORMUL 20 HOH *400(H2 O) HELIX 1 1 THR A 24 GLY A 35 1 12 HELIX 2 2 ASN A 76 PHE A 80 5 5 HELIX 3 3 ASN A 81 MSE A 85 5 5 HELIX 4 4 ASN A 86 LYS A 91 1 6 HELIX 5 5 LEU A 115 SER A 127 1 13 HELIX 6 6 THR A 139 ASP A 143 5 5 HELIX 7 7 ASN A 149 ALA A 164 1 16 HELIX 8 8 ILE A 166 ASP A 168 5 3 HELIX 9 9 ASP A 176 TYR A 187 1 12 HELIX 10 10 THR A 201 GLU A 207 1 7 HELIX 11 11 VAL A 220 VAL A 223 5 4 HELIX 12 12 SER A 224 LEU A 234 1 11 HELIX 13 13 THR A 245 GLY A 256 1 12 HELIX 14 14 TYR A 264 PHE A 269 5 6 SHEET 1 A 7 VAL A 51 VAL A 53 0 SHEET 2 A 7 THR A 38 ILE A 45 -1 N VAL A 44 O VAL A 52 SHEET 3 A 7 GLN A 131 ILE A 136 1 O GLU A 135 N LEU A 43 SHEET 4 A 7 PHE A 170 SER A 174 1 O GLN A 173 N GLY A 134 SHEET 5 A 7 LYS A 191 VAL A 196 1 O LYS A 191 N LEU A 172 SHEET 6 A 7 VAL A 215 PRO A 218 1 O SER A 217 N TYR A 194 SHEET 7 A 7 ARG A 237 VAL A 238 1 O ARG A 237 N TYR A 216 SHEET 1 B 4 VAL A 51 VAL A 53 0 SHEET 2 B 4 THR A 38 ILE A 45 -1 N VAL A 44 O VAL A 52 SHEET 3 B 4 ASP A 9 GLY A 12 1 N GLY A 12 O THR A 38 SHEET 4 B 4 GLY A 259 THR A 262 1 O ILE A 260 N GLN A 11 SHEET 1 C 2 MSE A 66 VAL A 67 0 SHEET 2 C 2 GLU A 70 ASP A 71 -1 O GLU A 70 N VAL A 67 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N ILE A 2 1555 1555 1.34 LINK C THR A 64 N MSE A 65 1555 1555 1.33 LINK C MSE A 65 N AMSE A 66 1555 1555 1.32 LINK C MSE A 65 N BMSE A 66 1555 1555 1.31 LINK C AMSE A 66 N VAL A 67 1555 1555 1.34 LINK C BMSE A 66 N VAL A 67 1555 1555 1.34 LINK C ALA A 84 N MSE A 85 1555 1555 1.33 LINK C MSE A 85 N ASN A 86 1555 1555 1.34 LINK C GLY A 96 N MSE A 97 1555 1555 1.33 LINK C MSE A 97 N LYS A 98 1555 1555 1.33 LINK C TYR A 182 N MSE A 183 1555 1555 1.34 LINK C MSE A 183 N HIS A 184 1555 1555 1.33 LINK C GLY A 235 N MSE A 236 1555 1555 1.34 LINK C MSE A 236 N ARG A 237 1555 1555 1.33 CISPEP 1 TRP A 241 THR A 242 0 -20.98 SITE 1 AC1 13 HIS A 13 ARG A 14 GLU A 40 ASP A 42 SITE 2 AC1 13 HIS A 55 GLU A 135 LYS A 137 PHE A 175 SITE 3 AC1 13 LEU A 195 TRP A 241 HOH A 300 HOH A 538 SITE 4 AC1 13 HOH A 668 SITE 1 AC2 4 HIS A 60 HIS A 61 GLU A 62 HOH A 544 SITE 1 AC3 7 TYR A 182 GLN A 186 GLU A 197 ASP A 219 SITE 2 AC3 7 THR A 221 HOH A 385 HOH A 583 SITE 1 AC4 5 ASP A 219 TRP A 241 THR A 242 HOH A 373 SITE 2 AC4 5 HOH A 466 SITE 1 AC5 6 LEU A 206 LEU A 209 SER A 210 PHE A 211 SITE 2 AC5 6 THR A 212 HOH A 524 SITE 1 AC6 6 LYS A 30 GLU A 92 ILE A 93 ASP A 94 SITE 2 AC6 6 HOH A 330 HOH A 625 SITE 1 AC7 4 THR A 242 ASN A 244 GLU A 248 HOH A 364 SITE 1 AC8 7 ARG A 17 ARG A 102 THR A 242 ASN A 244 SITE 2 AC8 7 ASP A 263 HOH A 484 HOH A 505 SITE 1 AC9 7 ASP A 155 ALA A 159 LYS A 162 TYR A 187 SITE 2 AC9 7 LYS A 199 HOH A 532 HOH A 617 SITE 1 BC1 4 ASP A 155 LYS A 199 HOH A 459 HOH A 616 SITE 1 BC2 8 GLU A 141 GLU A 250 THR A 251 SER A 254 SITE 2 BC2 8 HOH A 467 HOH A 570 HOH A 649 HOH A 683 SITE 1 BC3 3 ALA A 26 HOH A 360 HOH A 502 SITE 1 BC4 8 LEU A 19 LYS A 30 ASP A 68 GLY A 69 SITE 2 BC4 8 LYS A 107 HOH A 292 HOH A 378 HOH A 508 SITE 1 BC5 3 SER A 7 GLN A 131 HOH A 453 SITE 1 BC6 7 ARG A 102 PHE A 103 LYS A 104 SER A 105 SITE 2 BC6 7 TYR A 264 HOH A 418 HOH A 677 SITE 1 BC7 4 GLU A 92 ASP A 94 HOH A 423 HOH A 458 SITE 1 BC8 4 GLU A 207 LEU A 209 SER A 210 HOH A 676 SITE 1 BC9 5 ARG A 14 ARG A 17 HIS A 55 ARG A 102 SITE 2 BC9 5 HOH A 300 CRYST1 49.532 61.211 113.699 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020189 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016337 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008795 0.00000